Yang WY,Ji QH,Zhu DL,et al.Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.Chinese Medical Journal. 2009Thrice-daily biphasic insulin aspart 30 may be another therapeutic option ...
Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. Yang Wen-ying,Ji Qiu-he,Zhu Da-long,Yang Jin-kui,Chen Lu-lu,Liu Zhi-min,Yu De-min,Yan Li. Chinese Medical Journal . ...
P-33 Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetesPublication » P-33 Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes....
Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. Yang Wen-ying,Ji Qiu-he,Zhu Da-long,Yang Jin-kui,Chen Lu-lu,Liu Zhi-min,Yu De-min,Yan Li. Chinese Medical Journal ....